ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2021
Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The screening value of RT-LAMP and RT-PCR in the diagnosis of COVID-19: systematic review and meta-analysis.Journal of virological methods · 2022Pooled it
- Intensified screening for SARS-CoV-2 in 18 emergency departments in the Paris metropolitan area, France (DEPIST-COVID): A cluster-randomized, two-period, crossover trial.PLoS medicine · 2023Trial
- Impact on the German asymptomatic screening strategy based on actual user data from SARS-CoV-2 test centers.Scientific reports · 2023Article
- Epidemic Management via Imperfect Testing: A Multi-criterial Perspective.Bulletin of mathematical biology · 2023Article
- Data-driven multiscale dynamical framework to control a pandemic evolution with non-pharmaceutical interventions.PloS one · 2023Article
- Impact of community asymptomatic rapid antigen testing on covid-19 related hospital admissions: synthetic control study.BMJ (Clinical research ed.) · 2022Article
- Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic.Epidemiology and infection · 2022Article
- Mass Screening of SARS-CoV-2 With Rapid Antigen Tests in a Receding Omicron Wave: Population-Based Survey for Epidemiologic Evaluation.JMIR public health and surveillance · 2022Article
- Assessing the impact of COVID-19 mass testing in South Tyrol using a semi-parametric growth model.Scientific reports · 2022Article
- Guiding organisational decision-making about COVID-19 asymptomatic testing in workplaces: mixed-method study to inform an ethical framework.BMC public health · 2022Article
- Impact of Fast SARS-CoV-2 Molecular Point-Of-Care Testing on Patients' Length of Stay in an Emergency Department.Microbiology spectrum · 2022Article
- Perception of testing for COVID-19 during the first wave of the pandemic in Slovakia with emphasis on population age groups.Central European journal of public health · 2022Article
- What have European countries done to prevent the spread of COVID-19? Lessons from the COVID-19 Health system response monitor.Health policy (Amsterdam, Netherlands) · 2022Article
- Article
- Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France.BMC medicine · 2022Article
- The impact of control and mitigation strategies during the second wave of coronavirus infections in Spain and Italy.Scientific reports · 2022Article
- Testing for COVID-19 is Much More Effective When Performed Immediately Prior to Social Mixing.International journal of public health · 2022Article
- Perception of COVID-19 Testing in the Entire Population.Frontiers in public health · 2022Article
- Screening of COVID-19 cases through a Bayesian network symptoms model and psychophysical olfactory test.iScience · 2021Article
- Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We used a mathematical model to evaluate the impact of mass testing in the control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Under optimistic assumptions, one round of mass testing may reduce daily infections by up to 20-30%. Consequently, very frequent testing would be required to control a quickly growing epidemic if other control measures were to be relaxed. Mass testing is most relevant when epidemic growth remains limited through a combination of interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.